Taiwan · Delayed Price · Currency is TWD HanchorBio Statistics
Total Valuation
HanchorBio has a market cap or net worth of TWD 8.16 billion. The enterprise value is 8.28 billion.
| Market Cap | 8.16B |
| Enterprise Value | 8.28B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
HanchorBio has 119.81 million shares outstanding. The number of shares has increased by 120.26% in one year.
| Current Share Class | 119.81M |
| Shares Outstanding | 119.81M |
| Shares Change (YoY) | +120.26% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 27.69 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -7.75 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -15.08 |
Financial Position
The company has a current ratio of 1.79, with a Debt / Equity ratio of 0.38.
| Current Ratio | 1.79 |
| Quick Ratio | 1.73 |
| Debt / Equity | 0.38 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.21 |
| Interest Coverage | -205.20 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -295.19% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 74.44 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 40.29 |
| Average Volume (20 Days) | 293,348 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -873.12M |
| Pretax Income | -1.07B |
| Net Income | -1.07B |
| EBITDA | -848.65M |
| EBIT | -873.12M |
| Earnings Per Share (EPS) | -10.97 |
Balance Sheet
The company has 281.90 million in cash and 113.34 million in debt, giving a net cash position of 168.56 million or 1.41 per share.
| Cash & Cash Equivalents | 281.90M |
| Total Debt | 113.34M |
| Net Cash | 168.56M |
| Net Cash Per Share | 1.41 |
| Equity (Book Value) | 294.68M |
| Book Value Per Share | 0.01 |
| Working Capital | 204.26M |
Cash Flow
In the last 12 months, operating cash flow was -532.97 million and capital expenditures -16.36 million, giving a free cash flow of -549.32 million.
| Operating Cash Flow | -532.97M |
| Capital Expenditures | -16.36M |
| Free Cash Flow | -549.32M |
| FCF Per Share | -4.59 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
HanchorBio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -120.26% |
| Shareholder Yield | -120.26% |
| Earnings Yield | -13.10% |
| FCF Yield | -6.73% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |